These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25993513)

  • 1. Studying the effects of reproductive hormones and bacterial vaginosis on the glycome of lavage samples from the cervicovaginal cavity.
    Wang L; Koppolu S; Chappell C; Moncla BJ; Hillier SL; Mahal LK
    PLoS One; 2015; 10(5):e0127021. PubMed ID: 25993513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of bacterial vaginosis, as assessed by nugent criteria and hormonal status on glycosidases and lectin binding in cervicovaginal lavage samples.
    Moncla BJ; Chappell CA; Mahal LK; Debo BM; Meyn LA; Hillier SL
    PLoS One; 2015; 10(5):e0127091. PubMed ID: 26011704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Hormones and Vaginal Microflora on the Glycome of the Female Genital Tract: Cervical-Vaginal Fluid.
    Moncla BJ; Chappell CA; Debo BM; Meyn LA
    PLoS One; 2016; 11(7):e0158687. PubMed ID: 27437931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of reproductive hormones on the physical properties of cervicovaginal fluid.
    Chappell CA; Rohan LC; Moncla BJ; Wang L; Meyn LA; Bunge K; Hillier SL
    Am J Obstet Gynecol; 2014 Sep; 211(3):226.e1-7. PubMed ID: 24662718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
    Chappell CA; Isaacs CE; Xu W; Meyn LA; Uranker K; Dezzutti CS; Moncla BJ; Hillier SL
    Am J Obstet Gynecol; 2015 Aug; 213(2):204.e1-6. PubMed ID: 25818668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal Product Formulation Alters the Innate Antiviral Activity and Glycome of Cervicovaginal Fluids with Implications for Viral Susceptibility.
    Koppolu S; Wang L; Mathur A; Nigam JA; Dezzutti CS; Isaacs C; Meyn L; Bunge KE; Moncla BJ; Hillier SL; Rohan LC; Mahal LK
    ACS Infect Dis; 2018 Nov; 4(11):1613-1622. PubMed ID: 30183260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity.
    Thurman AR; Kimble T; Herold B; Mesquita PM; Fichorova RN; Dawood HY; Fashemi T; Chandra N; Rabe L; Cunningham TD; Anderson S; Schwartz J; Doncel G
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1139-52. PubMed ID: 26204200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Content of Cervicovaginal Fluid Is Altered During Bacterial Vaginosis.
    Ferreira CST; da Silva MG; de Pontes LG; Dos Santos LD; Marconi C
    J Low Genit Tract Dis; 2018 Apr; 22(2):147-151. PubMed ID: 29474232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervicovaginal inflammatory cytokines and sphingomyelinase in women with and without bacterial vaginosis.
    Hemalatha R; Ramalaxmi BA; KrishnaSwetha G; Kumar PU; Rao DM; Balakrishna N; Annapurna V
    Am J Med Sci; 2012 Jul; 344(1):35-9. PubMed ID: 22157388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elafin (SKALP/Trappin-2/proteinase inhibitor-3) is produced by the cervix in pregnancy and cervicovaginal levels are diminished in bacterial vaginosis.
    Stock SJ; Duthie L; Tremaine T; Calder AA; Kelly RW; Riley SC
    Reprod Sci; 2009 Dec; 16(12):1125-34. PubMed ID: 19723838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic signatures of bacterial vaginosis.
    Srinivasan S; Morgan MT; Fiedler TL; Djukovic D; Hoffman NG; Raftery D; Marrazzo JM; Fredricks DN
    mBio; 2015 Apr; 6(2):. PubMed ID: 25873373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
    Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
    APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
    Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menstrual cycle-dependent alterations in glycosylation: a roadmap for defining biomarkers of favorable and unfavorable mucus.
    Reynoso-Prieto M; Takeda M; Prakobphol A; Seidman D; Averbach S; Fisher S; Smith-McCune K
    J Assist Reprod Genet; 2019 May; 36(5):847-855. PubMed ID: 31073726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
    Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
    Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of hormonal contraception and pregnancy on sexually transmitted infections and on cervicovaginal microbiota in african sex workers.
    Borgdorff H; Verwijs MC; Wit FW; Tsivtsivadze E; Ndayisaba GF; Verhelst R; Schuren FH; van de Wijgert JH
    Sex Transm Dis; 2015 Mar; 42(3):143-52. PubMed ID: 25668647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.
    Mauck CK; Callahan MM; Baker J; Arbogast K; Veazey R; Stock R; Pan Z; Morrison CS; Chen-Mok M; Archer DF; Gabelnick HL
    Contraception; 1999 Jul; 60(1):15-24. PubMed ID: 10549448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
    Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK
    Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between maternal cervicovaginal proinflammatory cytokines concentrations during pregnancy and subsequent early-onset neonatal infection.
    Kalinka J; Krajewski P; Sobala W; Wasiela M; Brzezińska-Błaszczyk E
    J Perinat Med; 2006; 34(5):371-7. PubMed ID: 16965223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.